We are live on
!
Find out more
LVTX
LAVA Therapeutics
LVTX
LVTX
Delisted
LVTX was delisted on the 20th of November, 2025.
19 hedge funds and large institutions have $11.2M invested in LAVA Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
2.78% less ownership
Funds ownership: 28.9% → 26.12% (-2.8%)
5% less funds holding
Funds holding: 20 → 19 (-1)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
57% less capital invested
Capital invested by funds: $26.3M → $11.2M (-$15.1M)
Holders
19
Holders Change
-1
Holders Change %
-5%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BC
Bruce & Co
Chicago,
Illinois
|
+$1.6M |
| 2 |
CF
Cantor Fitzgerald
New York
|
+$149K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$89.8K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$78.1K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$57.4K |
